Cargando…

Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction

The ability of an AEF (axolemma-enriched fraction) to influence the proliferation, survival and differentiation of OPC (oligodendrocyte progenitor cells) was evaluated. Following addition of AEF to cultured OPC, the AEF associated with the outer surface of OPC so that subsequent metabolic events wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Becker-Catania, Sara G, Nelson, Julie K, Olivares, Shantel, Chen, Shu-Jen, DeVries, George H
Formato: Texto
Lenguaje:English
Publicado: American Society for Neurochemistry 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063503/
https://www.ncbi.nlm.nih.gov/pubmed/21345173
http://dx.doi.org/10.1042/AN20100035
_version_ 1782200807088717824
author Becker-Catania, Sara G
Nelson, Julie K
Olivares, Shantel
Chen, Shu-Jen
DeVries, George H
author_facet Becker-Catania, Sara G
Nelson, Julie K
Olivares, Shantel
Chen, Shu-Jen
DeVries, George H
author_sort Becker-Catania, Sara G
collection PubMed
description The ability of an AEF (axolemma-enriched fraction) to influence the proliferation, survival and differentiation of OPC (oligodendrocyte progenitor cells) was evaluated. Following addition of AEF to cultured OPC, the AEF associated with the outer surface of OPC so that subsequent metabolic events were likely mediated by direct AEF-OPC contact. Addition of AEF to the cultured OPC resulted in a dose- and time-dependent increase in proliferation that was partially dependent on Akt (protein kinase B) and MAPK (mitogen-activated protein kinase) activation. The major mitogen in an AEF-SE (soluble 2.0 M NaCl extract of the AEF) was identified as aFGF (acidic fibroblast growth factor) and accounted for 50% of the mitogenicity. The remaining 50% of the mitogenicity had properties consistent with bFGF (basic fibroblast growth factor) but was not unequivocally identified. Under conditions that limit the survival of OPC in culture, AEF treatment prolonged the survival of the OPC. Antigenic and morphological examination of the AEF-treated OPC indicated that the AEF treatment helped the OPC survive in a more immature state. The potential downstream metabolic pathways potentially activated in OPC by AEF and the consequences of these activated pathways are discussed. The results of these studies are consistent with the view that direct contact of axons with OPC stimulates their proliferation and survival while preventing their differentiation.
format Text
id pubmed-3063503
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Society for Neurochemistry
record_format MEDLINE/PubMed
spelling pubmed-30635032011-03-28 Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction Becker-Catania, Sara G Nelson, Julie K Olivares, Shantel Chen, Shu-Jen DeVries, George H ASN Neuro Research Article The ability of an AEF (axolemma-enriched fraction) to influence the proliferation, survival and differentiation of OPC (oligodendrocyte progenitor cells) was evaluated. Following addition of AEF to cultured OPC, the AEF associated with the outer surface of OPC so that subsequent metabolic events were likely mediated by direct AEF-OPC contact. Addition of AEF to the cultured OPC resulted in a dose- and time-dependent increase in proliferation that was partially dependent on Akt (protein kinase B) and MAPK (mitogen-activated protein kinase) activation. The major mitogen in an AEF-SE (soluble 2.0 M NaCl extract of the AEF) was identified as aFGF (acidic fibroblast growth factor) and accounted for 50% of the mitogenicity. The remaining 50% of the mitogenicity had properties consistent with bFGF (basic fibroblast growth factor) but was not unequivocally identified. Under conditions that limit the survival of OPC in culture, AEF treatment prolonged the survival of the OPC. Antigenic and morphological examination of the AEF-treated OPC indicated that the AEF treatment helped the OPC survive in a more immature state. The potential downstream metabolic pathways potentially activated in OPC by AEF and the consequences of these activated pathways are discussed. The results of these studies are consistent with the view that direct contact of axons with OPC stimulates their proliferation and survival while preventing their differentiation. American Society for Neurochemistry 2011-03-24 /pmc/articles/PMC3063503/ /pubmed/21345173 http://dx.doi.org/10.1042/AN20100035 Text en © 2011 The Author(s). http://creativecommons.org/licenses/by-nc/2.5/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Becker-Catania, Sara G
Nelson, Julie K
Olivares, Shantel
Chen, Shu-Jen
DeVries, George H
Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction
title Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction
title_full Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction
title_fullStr Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction
title_full_unstemmed Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction
title_short Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction
title_sort oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063503/
https://www.ncbi.nlm.nih.gov/pubmed/21345173
http://dx.doi.org/10.1042/AN20100035
work_keys_str_mv AT beckercataniasarag oligodendrocyteprogenitorcellsproliferateandsurviveinanimmaturestatefollowingtreatmentwithanaxolemmaenrichedfraction
AT nelsonjuliek oligodendrocyteprogenitorcellsproliferateandsurviveinanimmaturestatefollowingtreatmentwithanaxolemmaenrichedfraction
AT olivaresshantel oligodendrocyteprogenitorcellsproliferateandsurviveinanimmaturestatefollowingtreatmentwithanaxolemmaenrichedfraction
AT chenshujen oligodendrocyteprogenitorcellsproliferateandsurviveinanimmaturestatefollowingtreatmentwithanaxolemmaenrichedfraction
AT devriesgeorgeh oligodendrocyteprogenitorcellsproliferateandsurviveinanimmaturestatefollowingtreatmentwithanaxolemmaenrichedfraction